ICD-10-CM Billable Code

G20.B

Parkinson's disease with dyskinesia

Clinical Classification Guidelines

Excludes Type 1

  • drug induced dystonia (G24.0-)

Medical Intelligence & Overview

Parkinson's disease with dyskinesia is a neurological disorder that affects movement, often characterized by tremors, stiffness, and balance problems. The disease, which falls under the ICD-10 code G20.B, involves progressive deterioration of the nervous system. Dyskinesia, a key feature in this condition, refers to abnormal, involuntary movements that can develop as a side effect of long-term treatment, especially dopamine replacement therapy. Recognizing the symptoms and understanding the causes can aid in managing the condition effectively.

Causes & Symptoms

Clinical Causes: Progressive loss of dopamine-producing cells in the brain's substantia nigra. Long-term use of dopaminergic medications, which may lead to motor complications such as dyskinesia. Genetic factors that may predispose individuals to Parkinson's disease. Environmental exposures to certain toxins or chemicals that might contribute to the neurodegeneration. Age-related changes, as Parkinson's disease primarily affects older adults.

Key Symptoms: Resting tremor, often starting in a hand or fingers. Muscle rigidity or stiffness impacting movement. Bradykinesia, which is slowness of movement. Postural instability, leading to balance difficulties. Loss of automatic movements, such as blinking or swinging arms while walking. Speech changes, including softening or slurred speech. Dyskinesia: involuntary, dance-like movements that can occur during medication 'on' periods. Other motor symptoms such as shuffling gait, stooped posture, and freezing episodes.

Diagnostic & Treatment

Diagnosis Path: Diagnosis of Parkinson's disease with dyskinesia is primarily clinical, based on detailed neurological examination and medical history. Healthcare professionals look for characteristic motor symptoms and response to medication. No specific laboratory test definitively confirms the diagnosis, but imaging studies like dopamine transporter scans (DaTscan) can support the diagnosis. Differential diagnosis aims to exclude other parkinsonian syndromes and movement disorders.

Treatment Protocols: Medications: Dopamine replacement therapies such as levodopa combined with carbidopa are most common. Other drugs include dopamine agonists, MAO-B inhibitors, and COMT inhibitors. Management of dyskinesia: Adjusting medication doses or schedules, utilizing amantadine, or considering deep brain stimulation (DBS) in selected cases. Physical therapy: To enhance mobility, balance, and flexibility. Speech therapy: To address speech and swallowing difficulties. Occupational therapy: To assist with daily activities and adaptations. Lifestyle modifications: Regular exercise, a balanced diet, and adequate sleep can support overall health and symptom control.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is G20.B a billable ICD-10 code?
Yes, G20.B is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report G20.B?
Clinical documentation must specify the nature of Parkinson's disease with dyskinesia and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

disease dyskinesia